Skip to main content

Table 2 Comparison of selected symptoms in "fetal benzodiazepine syndrome", Zellweger syndrome and peroxisomal beta-oxidation (multifunctional protein-2) deficiency.

From: Pathogenesis of peroxisomal deficiency disorders (Zellweger syndrome) may be mediated by misregulation of the GABAergic system viathe diazepam binding inhibitor

 

"benzodiazepine embryofetopathy" [48]

Zellweger syndrome [2]

MFP2 deficiency [9]

hypotonia/floppy-baby syndrome

100% (8/8)

99% (94/95)

98% (41/42)

epicanthic folds

100% (8/8)

92% (33/36)

present1

feeding difficulties

88% (7/8)

96% (74/77)

91% (10/11)

mental retardation

86% (6/7)

100% (45/45)

yes

short upturned nose with low nasal bridge

75% (6/8)

100% (23/23)

present

micrognathia

63% (5/8)

100% (18/18)

present

Highly arched palate

50% (4/8)

95% (35/37)

present

abnormal ears

50% (4/8)

98% (39/40)

present

high forehead

present

97% (58/60)

present

neonatal seizures

no

92% (56/61)

95% (36/38)

neuronal migration defects

yes, in single case examined

yes, characteristic

88% (15/17)

  1. 1 79% (30/38) MFP2-deficient patients have a combination of dysmorphic features [9]. Numbers of affected and examined cases are indicated in parentheses.